Patents by Inventor Ming Ding

Ming Ding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240103097
    Abstract: The present disclosure provides a direct current (DC) transformer error detection apparatus for a pulsating harmonic signal, including a DC and pulsating harmonic current output module and an external detected input module, where the DC and pulsating harmonic current output module outputs a DC and a DC superimposed pulsating harmonic current to an internal sampling circuit and a self-calibrated standard resistor array; and the internal sampling circuit converts the input DC and the input DC superimposed pulsating harmonic current into a voltage signal, and sends the voltage signal to an analog-to-digital (AD) sampling and measurement component through a front-end conditioning circuit and a detected input channel. The DC transformer error detection apparatus can complete self-calibration for measurement of the DC and the pulsating harmonic signal on a test site.
    Type: Application
    Filed: August 17, 2022
    Publication date: March 28, 2024
    Inventors: Xin Zheng, Wenjing Yu, Tao Peng, Yi Fang, Ming Lei, Hong Shi, Ben Ma, Li Ding, Wei Wei, Linghua Li, He Yu, Tian Xia, Yingchun Wang, Sike Wang, Dongri Xie, Xin Wang, Bo Pang, Xianjin Rong
  • Publication number: 20240096347
    Abstract: Embodiments provide a method and an apparatus for determining speech similarity, and a program product, which relate to speech technology. The method includes: playing exemplary audio, and acquiring evaluation audio of a user, where the exemplary audio is audio of specified content that is read by using a specified language; acquiring a standard pronunciation feature corresponding to the exemplary audio, and extracting, from the evaluation audio, an evaluation pronunciation feature corresponding to the standard pronunciation feature, where the standard pronunciation feature is used to reflect a specific pronunciation of the specified content in the specified language; and determining a feature difference between the standard pronunciation feature and the evaluation pronunciation feature, and determining similarity between the evaluation audio and the exemplary audio according to the feature difference.
    Type: Application
    Filed: January 31, 2022
    Publication date: March 21, 2024
    Inventors: Rui XIA, Ming TU, Chen DING, Weiming ZHENG
  • Patent number: 11926787
    Abstract: A well cementing method is described for improving cementing quality by controlling the hydration heat of cement slurry. By controlling the degree and/or rate of hydration heat release from cement slurry, the method improves the hydration heat release during formation of cement with curing of cement slurry, improves the binding quality between the cement and the interfaces, and in turn improves the cementing quality at the open hole section and/or the overlap section. The cementing method improves cementing quality of oil and gas wells and reduces the risk of annular pressure.
    Type: Grant
    Filed: April 21, 2020
    Date of Patent: March 12, 2024
    Assignees: PetroChina Company Limited, CNPC Engineering Technology R&D Company Limited
    Inventors: Shuoqiong Liu, Hua Zhang, Jianzhou Jin, Ming Xu, Yongjin Yu, Fengzhong Qi, Congfeng Qu, Hong Yue, Youcheng Zheng, Wei Li, Yong Ma, Youzhi Zheng, Zhao Huang, Jinping Yuan, Zhiwei Ding, Chongfeng Zhou, Chi Zhang, Zishuai Liu, Hongfei Ji, Yuchao Guo, Xiujian Xia, Yong Li, Jiyun Shen, Huiting Liu, Yusi Feng, Bin Lyu
  • Patent number: 11928311
    Abstract: The present application discloses a communication method, a terminal, a server, a communication system, a computer device and a medium. The communication method includes that a server establishes a connection and feeds back a display control in response to requests of a first terminal and a second terminal; then, the server feeds back function feedback information in response to a function request of the first terminal, and feeds back function feedback information in response to a menu request of the second terminal; and the servers presents multiple interface components and maintains and updates each interface component in response to management operation of a third user.
    Type: Grant
    Filed: June 24, 2021
    Date of Patent: March 12, 2024
    Assignees: Beijing Zhongxiangying Technology Co., Ltd., BOE Technology Group Co., Ltd.
    Inventors: Ming Ding, Li Ma, Yang Wu, Wanwan Tang, Dachuan Wang, Hong Wang, Guangyu Shao, Chaozheng Liu
  • Patent number: 11912336
    Abstract: The present disclosure relates to a rear sub-frame assembly, applied to an electric vehicle main body, and rear sub-frame assembly comprises a rear sub-frame main body and positioning supports, rear sub-frame main body is bilateral symmetry structure; vehicle body connecting parts connected with rear sub-frame main body on upper portion of rear sub-frame main body, and battery pack guard plate connecting parts connected with rear sub-frame main body on lower portion of rear sub-frame main body are constructed on rear sub-frame main body, stabilizing rod mounting parts, upper control arm mounting parts and lower control arm mounting parts are further arranged on rear sub-frame main body respectively; the quantity of positioning supports respectively arranged close to left end and right end of rear sub-frame main body is two, and positioning parts matched with external positioning members to position rear sub-frame main body are constructed on two positioning supports respectively.
    Type: Grant
    Filed: December 22, 2020
    Date of Patent: February 27, 2024
    Assignee: GREAT WALL MOTOR COMPANY LIMITED
    Inventors: Wei Wang, Ming Chi, Weidong Ding, Yanmeng Song, Yonghui Song, Zhichao Chen, Changjian Cai
  • Publication number: 20230416737
    Abstract: Described are RNAi agents, compositions that include RNAi agents, and methods for inhibition of a double homeobox 4 (DUX4) gene. The DUX4 RNAi agents and RNAi agent conjugates disclosed herein inhibit the expression of a DUX4 gene. Pharmaceutical compositions that include one or more DUX4 RNAi agents, optionally with one or more additional therapeutics, are also described. Delivery of the described DUX4 RNAi agents to skeletal muscle cells in vivo, provides for inhibition of DUX4 gene expression and a reduction in DUX4 levels, which can provide a therapeutic benefit to subjects, including human subjects, suffering from certain skeletal muscle-related diseases or disorders including Facioscapulohumeral Muscular Dystrophy (FSID).
    Type: Application
    Filed: March 9, 2023
    Publication date: December 28, 2023
    Inventors: Zhi-Ming Ding, Jonathan Van Dyke, Xiaokai Li, Anthony Nicholas, Casi M. Schienebeck, Tao Pei, Zhao Xu, Teng Ai, Susan Phan, Susan Ramos-Hunter
  • Patent number: 11845937
    Abstract: Described are RNAi agents, compositions that include RNAi agents, and methods for inhibition of a double homeobox 4 (DUX4) gene. The DUX4 RNAi agents and RNAi agent conjugates disclosed herein inhibit the expression of a DUX4 gene. Pharmaceutical compositions that include one or more DUX4 RNAi agents, optionally with one or more additional therapeutics, are also described. Delivery of the described DUX4 RNAi agents to skeletal muscle cells in vivo, provides for inhibition of DUX4 gene expression and a reduction in DUX4 levels, which can provide a therapeutic benefit to subjects, including human subjects, suffering from certain skeletal muscle-related diseases or disorders including Facioscapulohumeral Muscular Dystrophy (FSHD).
    Type: Grant
    Filed: March 9, 2023
    Date of Patent: December 19, 2023
    Assignee: Arrowhead Pharmaceuticals, Inc.
    Inventors: Zhi-Ming Ding, Jonathan Van Dyke, Xiaokai Li, Anthony Nicholas, Casi M. Schienebeck, Tao Pei, Zhao Xu, Teng Ai, Susan Phan, Susan Ramos-Hunter
  • Patent number: 11835767
    Abstract: Embodiment of present invention provide an optical subassembly that includes a first, a second, and a third band filter (BF) each having a common port (CP), a port-A (PA), and a port-B (PB). The PA of the second BF is connected to the PA of the third BF and the PB of the first BF is connected to the PB of the third BF. The optical subassembly is adapted to route a first optical signal of a blue band from the PA to the CP of the first BF; to route the first optical signal from the CP of the second BF to the CP of the third BF; to route a second optical signal of a red band from the CP of the third BF to the CP of the first BF; and to route the second optical signal from the CP to the PB of the second BF.
    Type: Grant
    Filed: May 18, 2022
    Date of Patent: December 5, 2023
    Assignee: Alpine Optoelectronics Inc.
    Inventors: Tongqing Wang, Ming Ding
  • Publication number: 20230362768
    Abstract: A cell reselection method implemented by a terminal includes: camping on a first cell, where a first frequency of the first cell corresponds to a first PLMN; when the terminal device detects that a second cell satisfies a cell reselection condition and a second PLMN of the second cell and the first PLMN are not EPLMNs, skipping performing an action of reselection to the second cell, and adding the second cell to a barred list, where a second frequency of the second cell corresponds to a second PLMN; and when the terminal device detects that a third cell satisfies the cell reselection condition, and a third PLMN of the third cell and the first PLMN are EPLMNs, performing, an action of reselection to the third cell, where the third cell corresponds to the second frequency, and the third PLMN includes the first PLMN and the second PLMN.
    Type: Application
    Filed: October 29, 2021
    Publication date: November 9, 2023
    Applicant: Honor Device Co., Ltd.
    Inventors: Ming DING, Zhulin WANG, Longchang ZHU
  • Publication number: 20230325716
    Abstract: A pre-training service system is provided. The pre-training service system includes: a producer service module configured to provide a model producer with a model pre-training process for a pre-training dataset and generate a corresponding pre-training model; an optimizer service module configured to optimize the pre-training model according to a fine-tuning dataset provided by a model optimizer and obtain an optimized model; and a consumer service module configured to provide a model consumer with a service interface for the pre-training model or the optimized model, wherein the pre-training model or the optimized model is configured to perform inference on data provided by the model consumer and output a model prediction result.
    Type: Application
    Filed: December 23, 2022
    Publication date: October 12, 2023
    Inventors: Rui MEN, Chang ZHOU, Peng WANG, Yichang ZHANG, Junyang LIN, An YANG, Yong LI, Wei LIN, Ming DING, Xu ZOU, Zhengxiao DU, Jie TANG, Hongxia YANG, Jingren ZHOU
  • Publication number: 20230288816
    Abstract: The method for optimizing a light source in integrated circuit manufacturing, includes following steps: S1, providing an initial light source; S2, performing region segmentation according to light intensity distribution of the initial light source to obtain a plurality of sub light source regions; S3, providing at least two matching patterns and matching them with each sub light source region to obtain at least two matching results corresponding to each sub light source region; S4, performing calculating based on the at least two matching results and each sub light source region to obtain a best matching pattern corresponding to each sub light source region; and S5, generating a light source to be optimized based on the best matching pattern corresponding to each sub light source region.
    Type: Application
    Filed: May 19, 2023
    Publication date: September 14, 2023
    Applicant: SHENZHEN JINGYUAN INFORMATION TECHNOLOGY CO., LTD
    Inventors: Ge YAN, Ming DING
  • Publication number: 20230280538
    Abstract: Embodiment of present invention provide an optical subassembly that includes a first, a second, and a third band filter (BF) each having a common port (CP), a port-A (PA), and a port-B (PB). The PA of the second BF is connected to the PA of the third BF and the PB of the first BF is connected to the PB of the third BF. The optical subassembly is adapted to route a first optical signal of a blue band from the PA to the CP of the first BF; to route the first optical signal from the CP of the second BF to the CP of the third BF; to route a second optical signal of a red band from the CP of the third BF to the CP of the first BF; and to route the second optical signal from the CP to the PB of the second BF.
    Type: Application
    Filed: May 18, 2022
    Publication date: September 7, 2023
    Inventors: Tongqing Wang, Ming Ding
  • Patent number: 11750206
    Abstract: Example embodiments relate to systems and methods for analog-to-digital signal conversion. One embodiment includes a system for analog-to-digital signal conversion. The system includes an analog input signal. The system also includes a digital-to-analog converter configured to generate a reference signal. Further, the system includes an amplifier configured to amplify an error signal that includes a difference between the analog input signal and the reference signal. Additionally, the system includes a level-crossing based sampling circuit that includes a first comparator configured to compare the error signal with respect to a first reference level, and a second comparator configured to compare the error signal with respect to a second reference level, thereby generating event-based reset signals corresponding to a plurality of sampling instances in order to reset the digital-to-analog converter.
    Type: Grant
    Filed: December 28, 2021
    Date of Patent: September 5, 2023
    Assignee: Stichting IMEC Nederland
    Inventors: Ming Ding, Martijn Timmermans, Pieter Harpe
  • Publication number: 20230265430
    Abstract: Described are RNAi agents, compositions that include RNAi agents, and methods for inhibition of a double homeobox 4 (DUX4) gene. The DUX4 RNAi agents and RNAi agent conjugates disclosed herein inhibit the expression of a DUX4 gene. Pharmaceutical compositions that include one or more DUX4 RNAi agents, optionally with one or more additional therapeutics, are also described. Delivery of the described DUX4 RNAi agents to skeletal muscle cells in vivo, provides for inhibition of DUX4 gene expression and a reduction in DUX4 levels, which can provide a therapeutic benefit to subjects, including human subjects, suffering from certain skeletal muscle-related diseases or disorders including Facioscapulohumeral Muscular Dystrophy (FSHD).
    Type: Application
    Filed: March 9, 2023
    Publication date: August 24, 2023
    Inventors: Zhi-Ming Ding, Jonathan Van Dyke, Xiaokai Li, Anthony Nicholas, Casi M. Schienebeck, Tao Pei, Zhao Xu, Teng Ai, Susan Phan, Susan Ramos-Hunter
  • Publication number: 20230139166
    Abstract: The present disclosure relates to RNAi agents, e.g., double stranded RNAi agents, able to inhibit xanthine dehydrogenase (XDH) gene expression. Also disclosed are pharmaceutical compositions that include XDH RNAi agents and methods of use thereof. The XDH RNAi agents disclosed herein may be conjugated to targeting ligands to facilitate the delivery to cells, including to hepatocytes. Delivery of the XDH RNAi agents in vivo provides for inhibition of XDH gene expression. The RNAi agents can be used in methods of treatment of diseases, disorders, or symptoms mediated in part by XDH gene expression, such as gout and hyperuricemia.
    Type: Application
    Filed: October 12, 2022
    Publication date: May 4, 2023
    Inventors: Anthony NICHOLAS, Tao PEI, Zhao XU, Daniel BRAAS, Zhi-Ming DING
  • Publication number: 20230125671
    Abstract: The present disclosure relates to RNAi agents, e.g., double stranded RNAi agents, able to inhibit xanthine dehydrogenase (XDH) gene expression. Also disclosed are pharmaceutical compositions that include XDH RNAi agents and methods of use thereof. The XDH RNAi agents disclosed herein may be conjugated to targeting ligands to facilitate the delivery to cells, including to hepatocytes. Delivery of the XDH RNAi agents in vivo provides for inhibition of XDH gene expression. The RNAi agents can be used in methods of treatment of diseases, disorders, or symptoms mediated in part by XDH gene expression, such as gout and hyperuricemia.
    Type: Application
    Filed: October 28, 2022
    Publication date: April 27, 2023
    Inventors: Anthony NICHOLAS, Tao PEI, Zhao XU, Daniel BRAAS, Zhi-Ming DING
  • Patent number: 11638117
    Abstract: The present disclosure describes how a master beacon having a known UUID can be used to capture beacons within its range and superimpose a systematic address scheme on those beacons. The superimposed address scheme can then be used as a proxy for the individual beacons when developing applications that make use of the beacons. A master beacon automatically detects each beacon in a plurality of beacons and, for a set of beacons in the plurality of beacons, automatically changes either the first profile identifier or the second profile identifier for each beacon in the set of beacons. The change is such that the first profile identifier or the second profile identifier is identical for each beacon in the set of beacons and is also associated with the master beacon.
    Type: Grant
    Filed: March 19, 2021
    Date of Patent: April 25, 2023
    Assignee: CREEKSIDE INVESTMENTS INCORPORATED
    Inventors: Aaron Lyon Phillips-Lubimiv, Jay Fallah, Ming Ding, Samson Grant Kirk-Koffi
  • Patent number: 11629349
    Abstract: The present disclosure relates to RNAi agents, e.g., double stranded RNAi agents, able to inhibit xanthine dehydrogenase (XDH) gene expression. Also disclosed are pharmaceutical compositions that include XDH RNAi agents and methods of use thereof. The XDH RNAi agents disclosed herein may be conjugated to targeting ligands to facilitate the delivery to cells, including to hepatocytes. Delivery of the XDH RNAi agents in vivo provides for inhibition of XDH gene expression. The RNAi agents can be used in methods of treatment of diseases, disorders, or symptoms mediated in part by XDH gene expression, such as gout and hyperuricemia.
    Type: Grant
    Filed: May 19, 2022
    Date of Patent: April 18, 2023
    Assignee: ARROWHEAD PHARMACEUTICALS, INC.
    Inventors: Anthony Nicholas, Tao Pei, Zhao Xu, Daniel Braas, Zhi-Ming Ding
  • Patent number: 11606145
    Abstract: A silicon photonics based single wavelength 100 Gbit/s PAM4 DWDM transceiver in a pluggable form factor having a transmitter, said transmitter having: a DWDM laser source; a fiber array pigtail having a polarization maintaining fiber and an output single mode fiber; a silicon photonics modulator chip configured to optically connect to the DWDM laser source through the usage of the polarization maintaining fiber, a modulator driver chip connected to the silicon photonics modulator chip and an LC receptacle configured to optically connect to the silicon photonics modulator chip through the usage of the output single mode fiber. The disclosed transmitter may be further comprised of a reference loop within the silicon photonics modulator chip to allow for the utilization of a passive alignment approach for optically connected elements. The disclosed transceiver may be configured for use with C-band DWDM applications for utilization in applicable technologies, including 5G telecommunications.
    Type: Grant
    Filed: January 27, 2022
    Date of Patent: March 14, 2023
    Inventors: Tongqing Wang, Xingyu Zhang, Dawei Zheng, Ming Ding, Yong Li
  • Patent number: 11576024
    Abstract: This application provides a method and an apparatus for making an emergency call. The method includes: obtaining location information of UE; determining, based on the local information, whether the UE is located in a home country of an HPLMN of the UE; and when the UE is located in the home country of the HPLMN, if a predetermined condition is satisfied, initiating a VoWiFi emergency call by using an IMS APN of the HPLMN, where the predetermined condition includes: the UE has completed IMS registration, and a PLMN on which the UE camps includes no emergency APN. According to the method and apparatus for making an emergency call provided in this application, a VoWiFi emergency call success rate can be increased to some extent.
    Type: Grant
    Filed: August 12, 2019
    Date of Patent: February 7, 2023
    Assignee: Huawei Technologies Co., Ltd.
    Inventors: Ming Ding, Fenghui Dou, Jie Wu